至純科技(603690.SH):擬斥5000萬元參設私募股權基金 投資泛半導體裝備與材料領域
格隆匯12月17日丨至純科技(603690.SH)宣佈,公司與寧波宇杉共同投資名為“寧波宇微行至創業投資合夥企業(有限合夥)”的私募股權投資基金(簡稱“寧波宇微”)。根據合夥協議約定,該基金總規模上限為人民幣2億元,公司以有限合夥人身份擬使用自有資金出資人民幣5000萬元。
寧波宇微擬投資泛半導體裝備與材料領域,包括但不限於半導體制造及設備檢測,電子化學品,光學及其他泛半導體領域相關技術,具體投資標的及投資方案將由私募基金根據具體情況予以確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.